HIV-induced immune deficiency is associated with a higher risk of hepatocarcinoma, ANRS CO3 Aquitaine Cohort, France, 1998-2008

Journal of Hepatology

Volumn 55, Issue 5, 2011, Pages 1058-1062

  Bruyand, Mathias ^a,b   Dabis, Franois ^a,b   Vandenhende, Marie Anne ^b   Lazaro, Estibaliz ^b   Neau, Didier ^b   Leleux, Olivier ^a   Geffard, Stéphane ^a   Morlat, Philippe ^a,b   Chêne, Genevive ^a,b   Bonnet, Fabrice ^a,b  

^a INSERM   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

Hepatocarcinoma; HIV; Immunodeficiency; Risk

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FRANCE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NONHUMAN; PRIORITY JOURNAL; VIRUS TRANSMISSION;

ADULT; ANTI-RETROVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; CD4 LYMPHOCYTE COUNT; COINFECTION; FEMALE; FRANCE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TIME FACTORS;

EID: 80054754792     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.02.017     Document Type: Article

References (17)

1. F. Bonnet, C. Burty, C. Lewden, D. Costagliola, T. May, and V. Bouteloup Changes in cancer mortality among HIV-infected patients: the Mortalite 2005 Survey Clin Infect Dis 48 2009 633 639
2. D. Salmon-Ceron, E. Rosenthal, C. Lewden, V. Bouteloup, T. May, and C. Burty Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalite 2005 study J Hepatol 50 2009 736 745
3. T. Powles, D. Macdonald, M. Nelson, and J. Stebbing Hepatocellular cancer in HIV-infected individuals: tomorrow's problem? Expert Rev Anticancer Ther 6 2006 1553 1558 (Pubitemid 44883958)
4. T. Powles, D. Robinson, J. Stebbing, J. Shamash, M. Nelson, and B. Gazzard Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection J Clin Oncol 27 2009 884 890
5. D.C. MacDonald, M. Nelson, M. Bower, and T. Powles Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era World J Gastroenterol 14 2008 1657 1663 (Pubitemid 351493371)
6. J.R. Kramer, T.P. Giordano, J. Souchek, P. Richardson, L. Hwang, and H.B. YEl-Serag The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in US veterans with hepatitis C Am J Gastroenterol 100 2005 56 63 (Pubitemid 41623269)
7. K.A. McGinnis, S.L. Fultz, M. Skanderson, J. Conigliaro, K. Bryant, and A.C. Justice Hepatocellular carcinoma and non-Hodgkin's lymphoma: the roles of HIV, hepatitis C infection, and alcohol abuse J Clin Oncol 24 2006 5005 5009 (Pubitemid 46631403)
8. N. Brau, R.K. Fox, P. Xiao, K. Marks, Z. Naqvi, and L.E. Taylor Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a US - Canadian multicenter study J Hepatol 47 2007 527 537 (Pubitemid 47334759)
9. M. Guiguet, F. Boue, J. Cadranel, J.M. Lang, E. Rosenthal, and D. Costagliola Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study Lancet Oncol 10 2009 1152 1159
10. G.M. Clifford, M. Rickenbach, J. Polesel, L. Dal Maso, I. Steffen, and B. Ledergerber Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma AIDS 22 2008 2135 2141
11. R. Thiebaut, P. Morlat, H. Jacqmin-Gadda, D. Neau, P. Mercié, and F. Dabis Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment AIDS 14 2000 971 978 (Pubitemid 30336057)
12. D. Cox Regression models and life tables (with discussion) J R Stat Soc Ser B 34 1972 187 220
13. D. Commenges, L. Letenneur, and P. Joly Re: "Serum transferrin saturation, stroke incidence, and mortality in women and men. The NHANES I Epidemiologic Followup Study" Am J Epidemiol 146 1997 683 684
14. B.H. McGovern, Y. Golan, M. Lopez, D. Pratt, A. Lawton, and G. Moore The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients Clin Infect Dis 44 2007 431 437 (Pubitemid 46147629)
15. M.S. Sulkowski Hepatocellular carcinoma in HIV-infected patients comes of age: the convergence of epidemiology and treatment effectiveness J Hepatol 50 2009 736 745
16. E.E. Moodie, N. Pant Pai, and M.B. Klein Is antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV-mono-infected, HIV/hepatitis C co-infected cohorts PLoS ONE 4 2009 e4517
17. H.H. Thein, Q. Yi, G.J. Dore, and M.D. Krahn Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis AIDS 22 2008 1979 1991